Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis RA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02626026
What this trial is testing

Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 42
Testing effectiveness (Phase 2)Ended earlyNCT04078191
What this trial is testing

Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA

Who this might be right for
Rheumatoid Arthritis
Navidea Biopharmaceuticals 20
Testing effectiveness (Phase 2)Ended earlyNCT02603146
What this trial is testing

Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis

Who this might be right for
Healthy ParticipantsRheumatoid Arthritis (RA) Prevention
National Institute of Allergy and Infectious Diseases (NIAID) 144
Testing effectiveness (Phase 2)Ended earlyNCT01264770
What this trial is testing

Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
AstraZeneca 644
Testing effectiveness (Phase 2)Study completedNCT04004429
What this trial is testing

The Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint Disease

Who this might be right for
Rheumatoid Arthritis
SynAct Pharma Aps 105
Testing effectiveness (Phase 2)Ended earlyNCT00805467
What this trial is testing

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

Who this might be right for
Rheumatoid Arthritis
AstraZeneca 624
Not applicableEnded earlyNCT04941729
What this trial is testing

Study to Evaluate the Safety and Efficacy of OR3O™ Dual Mobility System vs. Conventional Single Bearing Design Total Hip System

Who this might be right for
Degenerative Hip Joint DiseaseRheumatoid Arthritis (RA)Femoral Neck Fractures+4 more
Smith & Nephew Medical (Shanghai) Ltd 24
Not applicableStudy completedNCT06804356
What this trial is testing

Poly-L/D-lactide Implant (RegJoint) Versus Tendon Interposition for Trapeziometacarpal Inflammatory Arthritis: a 15-year Follow-up

Who this might be right for
Rheumatoid Arthritis (RA)
Helsinki University Central Hospital 21
Not applicableStudy completedNCT01672970
What this trial is testing

A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 291
Not applicableUnknownNCT05754112
What this trial is testing

JAK-i on RA B-lymphocytes Tolerance and Disease Resolution Through JAK Signaling In Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Post-approval studies (Phase 4)Study completedNCT02602704
What this trial is testing

Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients

Who this might be right for
Arthritis, Rheumatoid
Hanyang University 114
Not applicableStudy completedNCT05227885
What this trial is testing

The Effects of Nutritional on Disease Activity and Functional Status in RA

Who this might be right for
Rheumatoid Arthritis
Balikesir University 100
Not applicableStudy completedNCT04340115
What this trial is testing

Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 4,211
Not applicableStudy completedNCT01078116
What this trial is testing

Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Abbott 124
Testing effectiveness (Phase 2)Looking for participantsNCT06991114
What this trial is testing

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Who this might be right for
Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)Systemic Sclerosis (SSc)+6 more
Artiva Biotherapeutics, Inc. 90
Not applicableStudy completedNCT01166620
What this trial is testing

Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 4,000
Large-scale testing (Phase 3)Ended earlyNCT01770379
What this trial is testing

Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 242
Not applicableLooking for participantsNCT07403188
What this trial is testing

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

Who this might be right for
Refractory Lupus NephritisMyasthaenia GravisStiff Person Syndrome+4 more
Kyverna Therapeutics 70
Not applicableEnded earlyNCT01577264
What this trial is testing

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)

Who this might be right for
Rheumatoid ArthritisCrohn's Disease
UCB Pharma 199
Testing effectiveness (Phase 2)Study completedNCT00256919
What this trial is testing

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 51
Next Page